Close this search box.

2020 highlights Pivot Park Community

Despite Covid-19 the Pivot Park Community managed to reach many successes in 2020. Pivot Park is very proud of the Community! Read here a short summary of the highlights of our Community members and click on the article to read more:

Month Company News
January Atro Medical Meniscus prosthesis from ATRO Medical receives FDA Breakthrough Device Designation
January Ardena Ardena has announced that it has been acquired by GHO Capital, the European specialist investor in healthcare
February PharmaCytics PharmaCytics wint Innovation for Health Award
March Citryll Citryll’s landmark paper published in Nature’s journal
April Innatoss Innatoss werkt hard aan een bloedtest om te kijken of mensen Covid-19 hebben gehad.
April Pivot Park Pivot Park investeert in strijd tegen corona
April InProcess LSP Tiofarma en InProcess-LSP werken samen aan Propofol nano-emulsie
May BioConnection Nieuwe productie faciliteit BioConnection
May Pivot Park Raamovereenkomst met IBN
May NTRC Novel Screening Assay NTRC / PPSC published in SLAS Discovery
May Pivot Park Screening Centre Novel Screening Assay for Arginase-1 Inhibitors published in SLAS Discovery
June PimBio PimBio receives a grant for feasibility study
July Citryll Citryll completes € 18.5 M fundraise to develop CIT-013, an antibody targeting Neutrophil Extracellular Traps
August BG Legal receives grant for AI knowledge platform
July Atro Medical EUROSTARS verstrekt financiering voor de eerste laterale meniscusprothese
September Synnafix Synnafix recognized with Best ADC Platform Technology Award
October Glycostem FDA grants Glycostem’s oNKord® Orphan Drug Designation for Multiple Myeloma
November PharmaCytics PharmaCytics and Madam Therapeutics announce collaboration to develop a new class of oral anti-biotics.
November Lead Pharma Lead Pharma enters into a Research Collaboration with Roche
November Pivot Park Pharming will join Pivot Park
November Pivot Park Winners Venture Challenge 2020
November InProcess LSP InProcess-LSP contributed successfully to Covid-19 vaccine
December Glycostem Glycostem and Ghent University announced a license agreement on NK cell therapy technology
December Pivot Park Pivot Park haalt lectoraat Drug Discovery naar Oss







Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?


The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.